Skip to main content
Erschienen in: Journal of Nephrology 2/2017

01.04.2017 | Original Article

Thyroid function and cardiovascular events in chronic kidney disease patients

verfasst von: Baris Afsar, Mahmut Ilker Yilmaz, Dimitrie Siriopol, Hilmi Umut Unal, Mutlu Saglam, Murat Karaman, Mustafa Gezer, Alper Sonmez, Tayfun Eyileten, Ibrahim Aydin, Salih Hamcan, Yusuf Oguz, Adrian Covic, Mehmet Kanbay

Erschienen in: Journal of Nephrology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Abnormalities of thyroid function are commonly seen in chronic kidney disease (CKD) patients. They are associated with adverse clinical conditions such as atherosclerosis, endothelial dysfunction, inflammation and abnormal blood pressure variability. We investigated the association between thyroid disorders and endothelial function, assessed by flow-mediated dilatation (FMD) and carotid intima-media thickness (CIMT), and cardiovascular events (CVE) in CKD patients.

Materials and methods

This observational cohort study included 305 CKD (stages 1–5) patients. Routine biochemistry, including free T3, free T4 and thyroid stimulating hormone, fibroblast growth factor-23 (FGF-23) and FMD, CIMT were measured. We divided patients into four groups according to thyroid hormone status: euthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, and euthyroid sick syndrome. Fatal and composite CVE were recorded for a median 29 months.

Results

Patients with subclinical hypothyroidism had a higher prevalence of hypertension and diabetes and also were more likely to have higher values of systolic CIMT, phosphorus, intact parathormone (iPTH), FGF-23, homeostasis model assessment-insulin resistance and lower levels of FMD than euthyroid patients. In the unadjusted survival analysis, subclinical hypothyroidism and euthyroid sick syndrome were associated with an increased risk for the outcome as compared with euthyroidism [hazard ratio 30.63 (95 % confidence interval 12.27–76.48) and 12.17 (3.70–39.98), respectively]. The effects of subclinical hypothyroidism and euthyroid sick syndrome were maintained even in fully adjusted models.

Conclusion

We demonstrated that subclinical hypothyroidism and euthyroid sick syndrome are associated with increased CVE in CKD patients. Further studies are needed to explore these issues.
Literatur
1.
Zurück zum Zitat Iglesias P, Diez JJ (2009) Thyroid dysfunction and kidney disease. Eur J Endocrinol 160(4):503–515CrossRefPubMed Iglesias P, Diez JJ (2009) Thyroid dysfunction and kidney disease. Eur J Endocrinol 160(4):503–515CrossRefPubMed
2.
Zurück zum Zitat Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S (2002) Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes 110(8):408–415CrossRefPubMed Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S (2002) Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes 110(8):408–415CrossRefPubMed
3.
Zurück zum Zitat Lo JC, Chertow GM, Go AS, Hsu CY (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67(3):1047–1052CrossRefPubMed Lo JC, Chertow GM, Go AS, Hsu CY (2005) Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 67(3):1047–1052CrossRefPubMed
4.
Zurück zum Zitat Rhee CM, Brent GA, Kovesdy CP, Soldin OP, Nguyen D, Budoff MJ et al (2015) Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. Nephrol Dial Transplant 30(5):724–737CrossRefPubMed Rhee CM, Brent GA, Kovesdy CP, Soldin OP, Nguyen D, Budoff MJ et al (2015) Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients. Nephrol Dial Transplant 30(5):724–737CrossRefPubMed
5.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305CrossRefPubMed Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305CrossRefPubMed
6.
Zurück zum Zitat Hataya Y, Igarashi S, Yamashita T, Komatsu Y (2013) Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients. Clin Exp Nephrol 17(4):525–531CrossRefPubMed Hataya Y, Igarashi S, Yamashita T, Komatsu Y (2013) Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients. Clin Exp Nephrol 17(4):525–531CrossRefPubMed
7.
Zurück zum Zitat Karanikas G, Schutz M, Szabo M, Becherer A, Wiesner K, Dudczak R et al (2004) Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol 24(1):41–45CrossRefPubMed Karanikas G, Schutz M, Szabo M, Becherer A, Wiesner K, Dudczak R et al (2004) Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol 24(1):41–45CrossRefPubMed
8.
Zurück zum Zitat Yang JW, Han ST, Song SH, Kim MK, Kim JS, Choi SO et al (2012) Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria. Ren Fail 34(3):364–372CrossRefPubMed Yang JW, Han ST, Song SH, Kim MK, Kim JS, Choi SO et al (2012) Serum T3 level can predict cardiovascular events and all-cause mortality rates in CKD patients with proteinuria. Ren Fail 34(3):364–372CrossRefPubMed
9.
Zurück zum Zitat Tatar E, Kircelli F, Asci G, Carrero JJ, Gungor O, Demirci MS et al (2011) Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol 6(9):2240–2246CrossRefPubMedPubMedCentral Tatar E, Kircelli F, Asci G, Carrero JJ, Gungor O, Demirci MS et al (2011) Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients. Clin J Am Soc Nephrol 6(9):2240–2246CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H et al (2011) Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol 33(1):25–32CrossRefPubMed Yilmaz MI, Sonmez A, Karaman M, Ay SA, Saglam M, Yaman H et al (2011) Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease. Am J Nephrol 33(1):25–32CrossRefPubMed
11.
Zurück zum Zitat Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR et al (2007) Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med 262(6):690–701CrossRefPubMed Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR et al (2007) Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med 262(6):690–701CrossRefPubMed
12.
Zurück zum Zitat Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A et al (2007) Relation between serum thyroid hormone and ‘nondipper’ circadian blood pressure variability. Kidney Blood Press Res 30(6):416–420CrossRefPubMed Kanbay M, Turgut F, Karakurt F, Isik B, Alkan R, Akcay A et al (2007) Relation between serum thyroid hormone and ‘nondipper’ circadian blood pressure variability. Kidney Blood Press Res 30(6):416–420CrossRefPubMed
13.
Zurück zum Zitat Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E et al (2011) Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol 33(4):305–312CrossRefPubMed Ozen KP, Asci G, Gungor O, Carrero JJ, Kircelli F, Tatar E et al (2011) Nutritional state alters the association between free triiodothyronine levels and mortality in hemodialysis patients. Am J Nephrol 33(4):305–312CrossRefPubMed
14.
Zurück zum Zitat Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P (2006) Low triiodothyronine and survival in end-stage renal disease. Kidney Int 70(3):523–528CrossRefPubMed Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P (2006) Low triiodothyronine and survival in end-stage renal disease. Kidney Int 70(3):523–528CrossRefPubMed
15.
Zurück zum Zitat Rhee CM, Alexander EK, Bhan I, Brunelli SM (2013) Hypothyroidism and mortality among dialysis patients. Clin J Am Soc Nephrol 8(4):593–601CrossRefPubMed Rhee CM, Alexander EK, Bhan I, Brunelli SM (2013) Hypothyroidism and mortality among dialysis patients. Clin J Am Soc Nephrol 8(4):593–601CrossRefPubMed
16.
Zurück zum Zitat Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F et al (2009) Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother 63(10):742–753CrossRefPubMed Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F et al (2009) Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother 63(10):742–753CrossRefPubMed
17.
Zurück zum Zitat Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344(7):501–509CrossRefPubMed Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344(7):501–509CrossRefPubMed
18.
Zurück zum Zitat Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P et al (2006) Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens 24(10):2039–2046CrossRefPubMed Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P et al (2006) Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease. J Hypertens 24(10):2039–2046CrossRefPubMed
19.
Zurück zum Zitat National Kidney F (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1–S201 National Kidney F (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42(4 Suppl 3):S1–S201
20.
Zurück zum Zitat Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470CrossRefPubMed Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470CrossRefPubMed
21.
Zurück zum Zitat Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU et al (2012) Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 36(3):228–237CrossRefPubMed Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU et al (2012) Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 36(3):228–237CrossRefPubMed
22.
Zurück zum Zitat Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115CrossRefPubMed Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340(8828):1111–1115CrossRefPubMed
23.
Zurück zum Zitat Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265CrossRefPubMed Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39(2):257–265CrossRefPubMed
24.
Zurück zum Zitat Rhee CM, Curhan GC, Alexander EK, Bhan I, Brunelli SM (2013) Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab 98(6):2326–2336CrossRefPubMedPubMedCentral Rhee CM, Curhan GC, Alexander EK, Bhan I, Brunelli SM (2013) Subclinical hypothyroidism and survival: the effects of heart failure and race. J Clin Endocrinol Metab 98(6):2326–2336CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Drechsler C, Schneider A, Gutjahr-Lengsfeld L, Kroiss M, Carrero JJ, Krane V et al (2014) Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis 63(6):988–996CrossRefPubMed Drechsler C, Schneider A, Gutjahr-Lengsfeld L, Kroiss M, Carrero JJ, Krane V et al (2014) Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis 63(6):988–996CrossRefPubMed
26.
Zurück zum Zitat Mariani LH, Berns JS (2012) The renal manifestations of thyroid disease. J Am Soc Nephrol 23(1):22–26CrossRefPubMed Mariani LH, Berns JS (2012) The renal manifestations of thyroid disease. J Am Soc Nephrol 23(1):22–26CrossRefPubMed
27.
28.
Zurück zum Zitat Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86(2):732–737CrossRefPubMed Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G (2001) Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 86(2):732–737CrossRefPubMed
29.
Zurück zum Zitat Angiolillo DJ, Bernardo E, Sabate M, Jimenez-Quevedo P, Costa MA, Palazuelos J et al (2007) Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 50(16):1541–1547CrossRefPubMed Angiolillo DJ, Bernardo E, Sabate M, Jimenez-Quevedo P, Costa MA, Palazuelos J et al (2007) Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 50(16):1541–1547CrossRefPubMed
30.
Zurück zum Zitat Gurbel PA (2006) The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor. Rev Cardiovasc Med 7(Suppl 4):S20–S28PubMed Gurbel PA (2006) The relationship of platelet reactivity to the occurrence of post-stenting ischemic events: emergence of a new cardiovascular risk factor. Rev Cardiovasc Med 7(Suppl 4):S20–S28PubMed
31.
Zurück zum Zitat Chadarevian R, Bruckert E, Giral P, Turpin G (1999) Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinolysis 10(8):481–486CrossRefPubMed Chadarevian R, Bruckert E, Giral P, Turpin G (1999) Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinolysis 10(8):481–486CrossRefPubMed
33.
Zurück zum Zitat Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39(4):695–701CrossRefPubMed Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39(4):695–701CrossRefPubMed
34.
Zurück zum Zitat Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A et al (2010) Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 31(5):419–425CrossRefPubMedPubMedCentral Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A et al (2010) Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 31(5):419–425CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M (2011) Renal anemia of inflammation: the name is self-explanatory. Blood Purif 32(3):220–225CrossRefPubMed Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M (2011) Renal anemia of inflammation: the name is self-explanatory. Blood Purif 32(3):220–225CrossRefPubMed
36.
Zurück zum Zitat Fernandez-Reyes MJ, Sanchez R, Heras M, Tajada P, Iglesias P, Garcia L et al (2009) Can FT3 levels facilitate the detection of inflammation or catabolism and malnutrition in dialysis patients? Nefrologia 29(4):304–310PubMed Fernandez-Reyes MJ, Sanchez R, Heras M, Tajada P, Iglesias P, Garcia L et al (2009) Can FT3 levels facilitate the detection of inflammation or catabolism and malnutrition in dialysis patients? Nefrologia 29(4):304–310PubMed
37.
Zurück zum Zitat Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F (2005) Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol 16(9):2789–2795CrossRefPubMed Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F (2005) Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol 16(9):2789–2795CrossRefPubMed
38.
Zurück zum Zitat Wiederkehr MR, Kalogiros J, Krapf R (2004) Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 19(5):1190–1197CrossRefPubMed Wiederkehr MR, Kalogiros J, Krapf R (2004) Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 19(5):1190–1197CrossRefPubMed
Metadaten
Titel
Thyroid function and cardiovascular events in chronic kidney disease patients
verfasst von
Baris Afsar
Mahmut Ilker Yilmaz
Dimitrie Siriopol
Hilmi Umut Unal
Mutlu Saglam
Murat Karaman
Mustafa Gezer
Alper Sonmez
Tayfun Eyileten
Ibrahim Aydin
Salih Hamcan
Yusuf Oguz
Adrian Covic
Mehmet Kanbay
Publikationsdatum
01.04.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 2/2017
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-016-0300-y

Weitere Artikel der Ausgabe 2/2017

Journal of Nephrology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.